VERTEX PHARMACEUTICALS INC / MA — Director's Dealing 2012

Jul 26, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VERTEX PHARMACEUTICALS INC / MA (VRTX)
CIK: 0000875320
Period of Report: 2012-07-25

Reporting Person: LEIDEN JEFFREY M (CEO & President)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-07-25	Employee StockOption (right to buy)	$48.74	A	118000	Acquired	2022-07-24	Common Stock (118000)	Direct

Footnotes

F1: The option vests in 16 quarterly installments beginning on 10/25/2012.